Question to the Department of Health and Social Care:

To ask Her Majesty's Government what budget they have set for the purchase of new Antiviral or Monoclonal Antibody drug treatments for COVID-19, including (1) those under current review like Evusheld, and (2) those under future review by the COVID-19 Antivirals and Therapeutics Taskforce; and if these should prove efficacious in the protection of immunosuppressed patients, whether this funding will be sufficient to meet current supply needs.

There is currently no funding allocated for these treatments. Funding for additional procurement of novel treatments is considered on a case-by-case basis, as guided by clinical need and subject to business cases and due process.